TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 839, doi. 10.2147/CMAR.S186080
- By:
- Publication type:
- Article
Works by Zheng, Ming-jun
Results: 5
1
2
Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 7745, doi. 10.2147/OTT.S175009
- By:
- Publication type:
- Article
4
Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 7, p. 11023, doi. 10.1002/jcp.27926
- By:
- Publication type:
- Article
5
Human epididymis protein 4 promotes P-glycoprotein-mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
- Published in:
- Molecular Medicine Reports, 2021, v. 24, n. 1, p. N.PAG
- By:
- Publication type:
- Article